alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest studies

Every summary in our library, newest first, as a dated timeline.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 26,451–26,475 of 27,380 studies, newest first · page 1059 of 1096.

December 1995 11

  1. 1995-12-01

    Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients

    ✓ Peer-reviewed Tau biomarkers Neuroscience letters

    Key finding: IL-1 beta and IL-6 contents were significantly elevated in the CSF of de novo PD and AD patients in comparison to the control group. +2 more findings

    Full summary, score breakdown and related studies → Original source

  2. 1995-12-01

    Epidemiology of Presenile Alzheimer's Disease in Scotland (1974–88)

    ✓ Peer-reviewed Risk factors The British Journal of Psychiatry

    Key finding: We found that an ecological measure of socio-economic deprivation was related to VaD but not to AD PSD. +4 more findings

    Full summary, score breakdown and related studies → Original source

  3. 1995-12-01

    Image analysis of beta-amyloid load in Alzheimer's disease and relation to dementia severity

    ✓ Peer-reviewed Cognitive tests and assessment Lancet (London, England)

    Key finding: Several groups have developed transgenic models that overexpress the amyloid precursor protein or beta-amyloid and then develop AD-like neuropathology. +3 more findings

    Full summary, score breakdown and related studies → Original source

  4. 1995-12-01

    Autobiographical memory and executive function in early dementia of Alzheimer type

    ✓ Peer-reviewed Cognitive tests and assessment Neuropsychologia

    Key finding: Autobiographical memory, as assessed by autobiographical fluency and the Autobiographical Memory Interview (AMI), was impaired in DAT patients, even those with minimal disease. +3 more findings

    Full summary, score breakdown and related studies → Original source

  5. 1995-12-01

    [Parapsychotic disorders in mentally handicapped (particularly in Down's syndrome)]

    ✓ Peer-reviewed Down syndrome and Alzheimer's Annales medico-psychologiques

    Key finding: It starts with loosing vital aim and long lasting soliloquy. +4 more findings

    Full summary, score breakdown and related studies → Original source

  6. 1995-12-01

    Chronic elevation of S100 beta protein does not alter APP mRNA expression or promote beta-amyloid deposition in the brains of aging transgenic mice

    ✓ Peer-reviewed Down syndrome and Alzheimer's Brain research

    Key finding: These results leave open the possibility of focal changes in APP transcription and do not address possible effects of S100 beta on the complex processing known to occur with APP protein. +1 more finding

    Full summary, score breakdown and related studies → Original source

  7. 1995-12-01

    Neuropsychological test performance in African-American and white patients with Alzheimer's disease

    ✓ Peer-reviewed Disparities Neurology

    Key finding: Little information exists on the performance of black versus white patients with Alzheimer's disease on neuropsychological tests for dementia. +1 more finding

    Full summary, score breakdown and related studies → Original source

  8. 1995-12-01

    Psychiatric and physical morbidity effects of dementia caregiving: prevalence, correlates, and causes

    ✓ Peer-reviewed Caregiving The Gerontologist

    Key finding: Physical morbidity was associated with patient problem behaviors and cognitive impairment, and with caregiver depression, anxiety, and perceived social support.

    Full summary, score breakdown and related studies → Original source

  9. 1995-12-01

    Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?

    ✓ Peer-reviewed Getting a diagnosis Molecular and chemical neuropathology

    Key finding: A marked increase in CSF-PHFtau was found in AD (2230 +/- 930 pg/mL), as compared with controls (640 +/- 230 pg/mL; p < 0.0001), vascular dementia, VAD (1610 +/- 840 pg/mL; p < 0.05), frontal lobe dementia, FLD (1530 +/- 1000 pg/mL; p < 0.05), Parkinson disease, PD (720 +/- 590 pg/mL; p < 0.0001), and patients with major depression (230 +/- 130 pg/mL; p < 0.0001). +1 more finding

    Full summary, score breakdown and related studies → Original source

  10. 1995-12-01

    Episodic memory changes are associated with the APOE-epsilon 4 allele in nondemented older adults

    ✓ Peer-reviewed Genetics Neurology

    Key finding: APOE- epsilon 4 and non-epsilon 4 groups did not significantly differ in demographic, mental status, and functional characteristics. +2 more findings

    Full summary, score breakdown and related studies → Original source

  11. 1995-12-01

    Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease

    ✓ Peer-reviewed Genetics Proceedings of the National Academy of Sciences of the United States of America

    Key finding: ApoE4 is associated with sporadic and late-onset familial Alzheimer disease (AD). +2 more findings

    Full summary, score breakdown and related studies → Original source

November 1995 10

  1. 1995-11-01

    Pain evaluation and management in the nursing home

    ✓ Peer-reviewed Health systems and care delivery Annals of internal medicine

    Key finding: Elderly nursing home residents are more sensitive to the side effects associated with many analgesic drugs, but this does not justify the failure to treat pain, especially in those who are terminally ill or near the end of life.

    Full summary, score breakdown and related studies → Original source

  2. 1995-11-01

    Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation

    ✓ Peer-reviewed Disease mechanisms Journal of neurochemistry

    Key finding: These endpoints indicate that AD brain protein may be more oxidized than that of control subjects. +2 more findings

    Full summary, score breakdown and related studies → Original source

  3. 1995-11-01

    Life-sustaining treatment preferences of hemodialysis patients: implications for advance directives

    ✓ Peer-reviewed End-of-life care Journal of the American Society of Nephrology : JASN

    Key finding: Mean ADAQ scores were: Dialysis Living Will, 71%; Centre for Bioethics Living Will, 70%; and Medical Directive, 60% (F = 8.27, P < 0.001 (repeat measures analysis of variance); the Dialysis Living Will and Centre for Bioethics Living Will scored significantly higher than the Medical Directive). +1 more finding

    Full summary, score breakdown and related studies → Original source

  4. 1995-11-01

    Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia

    ✓ Peer-reviewed Inflammation and the immune system Annals of neurology

    Key finding: In a prospectively clinically characterized population of acquired immunodeficiency syndrome (AIDS) patients we investigated the relationship between the clinical syndrome of HIV-associated dementia and the presence and relative quantity of immunocytochemical markers for HIV-1 (gp41 antibody), and for macrophages and microglia (HAM-56 antibody). +3 more findings

    Full summary, score breakdown and related studies → Original source

  5. 1995-11-01

    Apolipoprotein E allele epsilon 4, dementia, and cognitive decline in a population sample

    ✓ Peer-reviewed Brain tissue and pathology Lancet (London, England)

    Key finding: A population sample of persons aged 70 years and over was interviewed in 1990-91 to ascertain the presence of dementia or cognitive impairment. +3 more findings

    Full summary, score breakdown and related studies → Original source

  6. 1995-11-01

    Amyloid beta peptide potentiates cytokine secretion by interleukin-1 beta-activated human astrocytoma cells

    ✓ Peer-reviewed Risk genes beyond APOE Proceedings of the National Academy of Sciences of the United States of America

    Key finding: Recent descriptions of in vitro neurotoxic effects of A beta support this hypothesis and suggest toxicity might be mediated by A beta-induced neuronal calcium disregulation. +3 more findings

    Full summary, score breakdown and related studies → Original source

  7. 1995-11-01

    Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins

    ✓ Peer-reviewed Risk genes beyond APOE Neuron

    Key finding: Age at onset of neophobia and age at death decrease with increasing levels of brain APP. +3 more findings

    Full summary, score breakdown and related studies → Original source

  8. 1995-11-01

    Excessive glutamine sensitivity in Alzheimer's disease and Down syndrome lymphocytes

    ✓ Peer-reviewed Down syndrome and Alzheimer's Journal of the neurological sciences

    Key finding: A highly significant decrease in mitotic index in the presence of exogenous glutamine was noted in patients presenting an Alzheimer type dementia with or without associated Down syndrome. +2 more findings

    Full summary, score breakdown and related studies → Original source

  9. 1995-11-01

    Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein

    ✓ Peer-reviewed How common it is The New England journal of medicine

    Key finding: Even in elderly subjects without dementia, the apolipoprotein E genotype is related to the degree of deposition of beta-amyloid protein in the cerebral cortex. +1 more finding

    Full summary, score breakdown and related studies → Original source

  10. 1995-11-01

    Pain in cognitively impaired nursing home patients

    ✓ Peer-reviewed How common it is Journal of pain and symptom management

    Key finding: Subjects demonstrated substantial cognitive impairment (mean Folstein Mini-Mental State exam score was 12.1 +/- 7.9), typically having deficits in memory, orientation, and visual spatial skills. +1 more finding

    Full summary, score breakdown and related studies → Original source

October 1995 4

  1. 1995-10-01

    Prevalence of Alzheimer's disease and dementia in two communities: Nigerian Africans and African Americans

    ✓ Peer-reviewed Health systems and care delivery The American journal of psychiatry

    Key finding: The age-adjusted prevalence rates of dementia (2.29%) and Alzheimer's disease (1.41%) in the Ibadan sample were significantly lower than those in the Indianapolis sample, both in the community-dwelling subjects alone (4.82% and 3.69%, respectively) and in the combined nursing home and community samples (8.24% and 6.24%, respectively). +1 more finding

    Full summary, score breakdown and related studies → Original source

  2. 1995-10-01

    Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases)

    ✓ Peer-reviewed Risk factors Brain pathology (Zurich, Switzerland)

    Key finding: This spongiform change is characterised by diffuse or focally clustered small round or oval vacuoles in the neuropil of the deep cortical layers, cerebellar cortex or subcortical grey matter, which might become confluent. +4 more findings

    Full summary, score breakdown and related studies → Original source

  3. 1995-10-01

    Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo

    ✓ Peer-reviewed Treatments Neuropharmacology

    Key finding: The data from the present study do not lend support to the idea that low affinity, open channel NMDA receptor blockers are also effective in models of epilepsy at doses having little effect on physiological processes. +4 more findings

    Full summary, score breakdown and related studies → Original source

  4. 1995-10-01

    Tau, ubiquitin, and alpha B-crystallin immunohistochemistry define the principal causes of degenerative frontotemporal dementia

    ✓ Peer-reviewed Drug development Archives of neurology

    Key finding: These findings indicate that immunostaining with these antibodies is essential for the evaluation of frontal dementia. +1 more finding

    Full summary, score breakdown and related studies → Original source

Browse the library by subject, with the full score breakdown →